BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 24145066)

  • 1. Dual topoisomerase I and II poisoning by chiral Ru(II) complexes containing 2-thiophenylimidazo[4,5-f][1,10]phenanthroline derivatives.
    Wang YC; Qian C; Peng ZL; Hou XJ; Wang LL; Chao H; Ji LN
    J Inorg Biochem; 2014 Jan; 130():15-27. PubMed ID: 24145066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topoisomerase IIα poisoning and DNA double-strand breaking by chiral ruthenium(ii) complexes containing 2-furanyl-imidazo[4,5-f][1,10]phenanthroline derivatives.
    Qian C; Wu J; Ji L; Chao H
    Dalton Trans; 2016 Jun; 45(26):10546-55. PubMed ID: 27226117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chiral ruthenium(II) anthraquinone complexes as dual inhibitors of topoisomerases I and II.
    Kou JF; Qian C; Wang JQ; Chen X; Wang LL; Chao H; Ji LN
    J Biol Inorg Chem; 2012 Jan; 17(1):81-96. PubMed ID: 21858685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, DNA-binding and topoisomerase inhibitory activity of ruthenium(II) polypyridyl complexes.
    Du KJ; Wang JQ; Kou JF; Li GY; Wang LL; Chao H; Ji LN
    Eur J Med Chem; 2011 Apr; 46(4):1056-65. PubMed ID: 21295892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, characterization and DNA-binding of novel chiral complexes delta- and lambda-[Ru(bpy)2L]2+ (L = o-mopip and p-mopip).
    Shi S; Liu J; Li J; Zheng KC; Huang XM; Tan CP; Chen LM; Ji LN
    J Inorg Biochem; 2006 Mar; 100(3):385-95. PubMed ID: 16457890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chiral ruthenium complexes induce apoptosis of tumor cell and interact with bovine serum albumin.
    Yuan F; Chen X; Liu Y; Zhang T; Sun D; Liu J
    Chirality; 2012 Feb; 24(2):174-80. PubMed ID: 22180296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and Evaluation of In Vitro DNA/Protein Binding Affinity, Antimicrobial, Antioxidant and Antitumor Activity of Mononuclear Ru(II) Mixed Polypyridyl Complexes.
    Putta VR; Chintakuntla N; Mallepally RR; Avudoddi S; K N; Nancherla D; V V N Y; R S P; Surya SS; Sirasani S
    J Fluoresc; 2016 Jan; 26(1):225-40. PubMed ID: 26555289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA-binding and photoactivated enantiospecific cleavage of chiral polypyridyl ruthenium(II) complexes.
    Zhang QL; Liu JH; Liu JZ; Zhang PX; Ren XZ; Liu Y; Huang Y; Ji LN
    J Inorg Biochem; 2004 Aug; 98(8):1405-12. PubMed ID: 15271518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxicity, apoptosis, cellular uptake, cell cycle arrest, photocleavage, and antioxidant activity of 1, 10-phenanthroline ruthenium(II) complexes.
    Liu YJ; Li ZZ; Liang ZH; Yao JH; Huang HL
    DNA Cell Biol; 2011 Oct; 30(10):839-48. PubMed ID: 21568758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ruthenium(II) mixed-ligand complex containing 2-(4'-benzyloxy-phenyl)imidazo[4,5-f][1,10]phenanthroline: synthesis, DNA-binding and photocleavage studies.
    Tan LF; Wang F; Chao H; Zhou YF; Weng C
    J Inorg Biochem; 2007 Apr; 101(4):700-8. PubMed ID: 17316812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stabilization of G-quadruplex DNA, inhibition of telomerase activity and live cell imaging studies of chiral ruthenium(II) complexes.
    Sun D; Liu Y; Liu D; Zhang R; Yang X; Liu J
    Chemistry; 2012 Apr; 18(14):4285-95. PubMed ID: 22367788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enantiomeric ruthenium(II) complexes binding to DNA: binding modes and enantioselectivity.
    Liu JG; Ye BH; Zhang QL; Zou XH; Zhen QX; Tian X; Ji LN
    J Biol Inorg Chem; 2000 Feb; 5(1):119-28. PubMed ID: 10766444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting topoisomerase II with the chiral DNA-intercalating ruthenium(II) polypyridyl complexes.
    Gao F; Chao H; Wang JQ; Yuan YX; Sun B; Wei YF; Peng B; Ji LN
    J Biol Inorg Chem; 2007 Sep; 12(7):1015-27. PubMed ID: 17659367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual inhibition of topoisomerases I and IIα by ruthenium(II) complexes containing asymmetric tridentate ligands.
    Du K; Liang J; Wang Y; Kou J; Qian C; Ji L; Chao H
    Dalton Trans; 2014 Dec; 43(46):17303-16. PubMed ID: 25315107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, DNA-binding and photocleavage of "light switch" complexes [Ru(bpy)2(pyip)]2+ and [Ru(phen)2(pyip)]2+.
    Liu XW; Shen YM; Lu JL; Chen YD; Li L; Zhang DS
    Spectrochim Acta A Mol Biomol Spectrosc; 2010 Oct; 77(2):522-7. PubMed ID: 20634127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chiral ruthenium(II) complexes with phenolic hydroxyl groups as dual poisons of topoisomerases I and IIα.
    Zhang P; Wang J; Huang H; Qiao L; Ji L; Chao H
    Dalton Trans; 2013 Jun; 42(24):8907-17. PubMed ID: 23661230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA Interaction, Photocleavage and Topoisomerase I Inhibition by Ru(II) Complex with a New Ligand Possessing Phenazine Unit.
    Liu XW; Shen YM; Shu JS; Xiao Y; Zhang SB; Lu JL
    J Fluoresc; 2015 Sep; 25(5):1527-35. PubMed ID: 26286067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ruthenium(II) polypyridyl complexes: synthesis and studies of DNA binding, photocleavage, cytotoxicity, apoptosis, cellular uptake, and antioxidant activity.
    Liu YJ; Liang ZH; Li ZZ; Yao JH; Huang HL
    DNA Cell Biol; 2011 Oct; 30(10):829-38. PubMed ID: 21395447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, characterization; DNA binding and antitumor activity of ruthenium(II) polypyridyl complexes.
    Srishailam A; Gabra NM; Kumar YP; Reddy KL; Devi CS; Anil Kumar D; Singh SS; Satyanarayana S
    J Photochem Photobiol B; 2014 Dec; 141():47-58. PubMed ID: 25318017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chiral ruthenium(II) complex Δ-[Ru(bpy)
    Bai M; Pan T; Yu G; Xie Q; Zeng Z; Zhang Y; Zhu D; Mu L; Qian J; Chang B; Mei WJ; Guan S
    Eur J Pharmacol; 2019 Jun; 853():49-55. PubMed ID: 30880177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.